Mechanisms involved in p53 downregulation by leptin in trophoblastic cells

Leptin, a 16-kDa polypeptide hormone, is produced by the adipocyte and can also be synthesized by placenta. We previously demonstrated that leptin promotes proliferation and survival in placenta, in part mediated by the p53 pathway. In this work, we investigated the mechanisms involved in leptin dow...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Toro, A.R
Otros Autores: Pérez-Pérez, A., Corrales Gutiérrez, I., Sánchez-Margalet, V., Varone, C.L
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: W.B. Saunders Ltd 2015
Materias:
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 18260caa a22017537a 4500
001 PAPER-13166
003 AR-BaUEN
005 20230518204326.0
008 190411s2015 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-84947038203 
024 7 |2 cas  |a 2 (2 amino 3 methoxyphenyl)chromone, 167869-21-8; mitogen activated protein kinase, 142243-02-5; phosphatidylinositol 3 kinase, 115926-52-8; Leptin; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-mdm2; Tumor Suppressor Protein p53 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a PLACD 
100 1 |a Toro, A.R. 
245 1 0 |a Mechanisms involved in p53 downregulation by leptin in trophoblastic cells 
260 |b W.B. Saunders Ltd  |c 2015 
270 1 0 |m Varone, C.L.; Química Biológica Ciudad Universitaria, Pabellón 2, piso 4, Argentina; email: cvarone@qb.fcen.uba.ar 
506 |2 openaire  |e Política editorial 
504 |a Maymo, J.L., Perez, A.P., Gambino, Y., Calvo, J.C., Sanchez-Margalet, V., Varone, C.L., Review: Leptin gene expression in the placenta-regulation of a key hormone in trophoblast proliferation and survival (2011) Placenta, 32, pp. S146-S153 
504 |a Levy, R., Nelson, D.M., To be, or not to be, that is the question. Apoptosis in human trophoblast (2000) Placenta, 21, pp. 1-13 
504 |a Heazell, A.E., Crocker, I.P., Live and let die - Regulation of villous trophoblast apoptosis in normal and abnormal pregnancies (2008) Placenta, 29, pp. 772-783 
504 |a Prives, C., Hall, P.A., The p53 pathway (1999) J. Pathol., 187, pp. 112-126 
504 |a Meek, D.W., Anderson, C.W., Posttranslational modification of p53: Cooperative integrators of function (2009) Cold Spring Harb. Perspect. Biol., 1, p. a000950 
504 |a Hock, A.K., Vousden, K.H., The role of ubiquitin modification in the regulation of p53 (2014) Biochim. Biophys. Acta, 1843, pp. 137-149 
504 |a Wade, M., Li, Y.C., Wahl, G.M., MDM2, MDMX and p53 in oncogenesis and cancer therapy (2013) Nat. Rev. Cancer, 13, pp. 83-96 
504 |a Pant, V., Lozano, G., Limiting the power of p53 through the ubiquitin proteasome pathway (2015) Genes Dev., 28, pp. 1739-1751 
504 |a Prives, C., Signaling to p53: Breaking the MDM2-p53 circuit (1998) Cell, 95, pp. 5-8 
504 |a Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., Friedman, J.M., Positional cloning of the mouse obese gene and its human homologue (1994) Nature, 372, pp. 425-432 
504 |a Flier, J.S., The adipocyte: Storage depot or node on the energy information superhighway? (1995) Cell, 80, pp. 15-18 
504 |a Sagawa, N., Yura, S., Itoh, H., Mise, H., Kakui, K., Korita, D., Takemura, M., Fujii, S., Role of leptin in pregnancy-a review (2002) Placenta, 23, pp. S80-S86 
504 |a Cervero, A., Horcajadas, J.A., Dominguez, F., Pellicer, A., Simon, C., Leptin system in embryo development and implantation: A protein in search of a function (2005) Reprod. Biomed. Online, 10, pp. 217-223 
504 |a Henson, M.C., Castracane, V.D., Leptin in pregnancy: An update (2006) Biol. Reprod., 74, pp. 218-229 
504 |a Madej, T., Boguski, M.S., Bryant, S.H., Threading analysis suggests that the obese gene product may be a helical cytokine (1995) FEBS Lett., 373, pp. 13-18 
504 |a Tartaglia, L.A., The leptin receptor (1997) J. Biol. Chem., 272, pp. 6093-6096 
504 |a Tessier, D.R., Ferraro, Z.M., Gruslin, A., Role of leptin in pregnancy: Consequences of maternal obesity (2013) Placenta, 34, pp. 205-211 
504 |a Bjorbak, C., Lavery, H.J., Bates, S.H., Olson, R.K., Davis, S.M., Flier, J.S., Myers, M.G., Jr., SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985 (2000) J. Biol. Chem., 275, pp. 40649-40657 
504 |a Challier, J., Galtier, M., Bintein, T., Cortez, A., Lepercq, J., Hauguel-De Mouzon, S., Placental leptin receptor isoforms in normal and pathological pregnancies (2003) Placenta, 24, pp. 92-99 
504 |a Perez-Perez, A., Maymo, J., Duenas, J.L., Goberna, R., Calvo, J.C., Varone, C., Sanchez-Margalet, V., Leptin prevents apoptosis of trophoblastic cells by activation of MAPK pathway (2008) Arch. Biochem. Biophys., 477, pp. 390-395 
504 |a Henson, M.C., Swan, K.F., O'Neil, J.S., Expression of placental leptin and leptin receptor transcripts in early pregnancy and at term (1998) Obstet. Gynecol., 92, pp. 1020-1028 
504 |a Gambino, Y.P., Maymo, J.L., Perez-Perez, A., Dueñas, J.L., Sánchez-Margalet, V., Calvo, J.C., Varone, C.L., 17Beta-estradiol enhances leptin expression in human placental cells through genomic and nongenomic actions (2010) Biol. Reprod., 83, pp. 42-51 
504 |a Gambino, Y.P., Maymo, J.L., Perez Perez, A., Calvo, J.L., Sánchez-Margalet, V., Varone, C.L., Elsevier trophoblast research award lecture: Molecular mechanisms underlying estrogen functions in trophoblastic cells - Focus on leptin expression (2012) Placenta, 33, pp. S63-S70 
504 |a Perez-Perez, A., Maymo, J., Gambino, Y., Guadix, P., Duenas, J.L., Varone, C., Sanchez-Margalet, V., Insulin enhances leptin expression in human trophoblastic cells (2013) Biol. Reprod., 89, p. 20 
504 |a Maymo, J.L., Perez Perez, A., Sanchez-Margalet, V., Duenas, J.L., Calvo, J.C., Varone, C.L., Up-regulation of placental leptin by human chorionic gonadotropin (2009) Endocrinology, 150, pp. 304-313 
504 |a Maymo, J.L., Perez Perez, A., Duenas, J.L., Calvo, J.C., Sanchez-Margalet, V., Varone, C.L., Regulation of placental leptin expression by cyclic adenosine 5'-monophosphate involves cross talk between protein kinase A and mitogen-activated protein kinase signaling pathways (2010) Endocrinology, 151, pp. 3738-3751 
504 |a Grosfeld, A., Turban, S., Andre, J., Cauzac, M., Challier, J.C., Hauguel-De Mouzon, S., Guerre-Millo, M., Transcriptional effect of hypoxia on placental leptin (2001) FEBS Lett., 502, pp. 122-126 
504 |a Bajoria, R., Sooranna, S.R., Ward, B.S., Chatterjee, R., Prospective function of placental leptin at maternal-fetal interface (2002) Placenta, 23, pp. 103-115 
504 |a Laivuori, H., Gallaher, M.J., Collura, L., Crombleholme, W.R., Markovic, N., Rajakumar, A., Hubel, C.A., Powers, R.W., Relationships between maternal plasma leptin, placental leptin mRNA and protein in normal pregnancy, pre-eclampsia and intrauterine growth restriction without pre-eclampsia (2006) Mol. Hum. Reprod., 12, pp. 551-556 
504 |a Magarinos, M.P., Sanchez-Margalet, V., Kotler, M., Calvo, J.C., Varone, C.L., Leptin promotes cell proliferation and survival of trophoblastic cells (2007) Biol. Reprod., 76, pp. 203-210 
504 |a Perez-Perez, A., Maymo, J., Gambino, Y., Duenas, J.L., Goberna, R., Varone, C., Sanchez-Margalet, V., Leptin stimulates protein synthesis-activating translation machinery in human trophoblastic cells (2009) Biol. Reprod., 81, pp. 826-832 
504 |a Perez-Perez, A., Gambino, Y., Maymo, J., Goberna, R., Fabiani, F., Varone, C., Sanchez-Margalet, V., MAPK and PI3K activities are required for leptin stimulation of protein synthesis in human trophoblastic cells (2010) Biochem. Biophys. Res. Commun., 396, pp. 956-960 
504 |a Toro, A.R., Maymo, J.L., Ibarbalz, F.M., Perez Perez, A., Maskin, B., Faletti, A.G., Sanchez Margalet, V., Varone, C.L., Leptin is an anti-apoptotic effector in placental cells involving p53 downregulation (2014) PLoS One, 9, p. e99187 
504 |a Shawn, L., Straszewski-Chavez, S.L., Abrahams, V.M., Alvero, A.B., Aldo, P.B., Ma, Y., Guller, S., Mor, G., The isolation and characterization of a novel telomerase immortalized first trimester trophoblast cell line, Swan 71 (2009) Placenta, 30, pp. 939-948 
504 |a Ramhorst, R., Fraccaroli, L., Aldo, P., Alvero, A.B., Cardenas, I., Leiros, C.P., Mor, G., Modulation and recruitment of inducible regulatory T cells by first trimester trophoblast cells (2012) Am. J. Reprod. Immunol., 67, pp. 17-27 
504 |a Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding (1976) Anal. Biochem., 72, pp. 248-254 
504 |a Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method (2001) Methods, 25, pp. 402-408 
504 |a Masuzaki, H., Ogawa, Y., Isse, N., Satoh, N., Okazaki, T., Shigemoto, M., Mori, K., Yoshimasa, Y., Human obese gene expression. Adipocyte-specific expression and regional differences in the adipose tissue (1995) Diabetes, 44, pp. 855-858 
504 |a Campfield, L.A., Smith, F.J., Guisez, Y., Devos, R., Burn, P., Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks (1995) Science (New York N. Y.), 269, pp. 546-549 
504 |a Barrientos, G., Toro, A., Moschansky, P., Cohen, M., Garcia, M.G., Rose, M., Maskin, B., Varone, C.L., Leptin promotes HLA-G expression on placental trophoblasts via the MEK/Erk and PI3K signaling pathways (2015) Placenta, 36, pp. 419-426 
504 |a Ashworth, C.J., Hoggard, N., Thomas, L., Mercer, J.G., Wallace, J.M., Lea, R.G., Placental leptin (2000) Rev. Reprod., 5, pp. 18-24 
504 |a Nelson, S.M., Coan, P.M., Burton, G.J., Lindsay, R.S., Placental structure in type 1 diabetes: Relation to fetal insulin, leptin, and IGF-I (2009) Diabetes, 58, pp. 2634-2641 
504 |a Iciek, R., Wender-Ozegowska, E., Zawiejska, A., Mikolajczak, P., Mrozikiewicz, P.M., Pietryga, M., Brazert, J., Placental leptin and its receptor genes expression in pregnancies complicated by type 1 diabetes (2013) J. Physiol. Pharmacol., 64, pp. 579-585 
504 |a Poston, L., Leptin and preeclampsia (2002) Semin. Reprod. Med., 20, pp. 131-138 
504 |a Perez-Perez, A., Sanchez-Jimenez, F., Maymo, J., Duenas, J.L., Varone, C., Sanchez-Margalet, V., Role of leptin in female reproduction (2015) Clin. Chem. Lab. Med., 53, pp. 15-28 
504 |a Saxena, N.K., Titus, M.A., Ding, X., Floyd, J., Srinivasan, S., Sitaraman, S.V., Anania, F.A., Leptin as a novel profibrogenic cytokine in hepatic stellate cells: Mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase (Erk) and Akt phosphorylation (2004) Faseb J., 18, pp. 1612-1614 
504 |a Bruno, A., Conus, S., Schmid, I., Simon, H.U., Apoptotic pathways are inhibited by leptin receptor activation in neutrophils (2005) J. Immunol., 174, pp. 8090-8096 
504 |a Najib, S., Sanchez-Margalet, V., Human leptin promotes survival of human circulating blood monocytes prone to apoptosis by activation of p42/44 MAPK pathway (2002) Cell. Immunol., 220, pp. 143-149 
504 |a Vogelstein, B., Lane, D., Levine, A.J., Surfing the p53 network (2000) Nature, 408, pp. 307-310 
504 |a Sharp, A.N., Heazell, A.E., Baczyk, D., Dunk, C.E., Lacey, H.A., Jones, C.J., Perkins, J.E., Crocker, I.P., Preeclampsia is associated with alterations in the p53-pathway in villous trophoblast (2014) PLoS One, 9, p. e87621 
504 |a Levy, R., Smith, S.D., Yusuf, K., Huettner, P.C., Kraus, F.T., Sadovsky, Y., Nelson, D.M., Trophoblast apoptosis from pregnancies complicated by fetal growth restriction is associated with enhanced p53 expression (2002) Am. J. Obstet.Gynecol., 186, pp. 1056-1061 
504 |a Oda, K., Arakawa, H., Tanaka, T., Matsuda, K., Tanikawa, C., Mori, T., Nishimori, H., Taya, Y., P53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53 (2000) Cell, 102, pp. 849-862 
504 |a Quenby, S., Brazeau, C., Drakeley, A., Lewis-Jones, D.I., Vince, G., Oncogene and tumour suppressor gene products during trophoblast differentiation in the first trimester (1998) Mol. Hum. Reprod., 4, pp. 477-481 
504 |a Marzusch, K., Ruck, P., Horny, H.P., Dietl, J., Kaiserling, E., Expression of the p53 tumour suppressor gene in human placenta: An immunohistochemical study (1995) Placenta, 16, pp. 101-104 
504 |a Barak, Y., Juven, T., Haffner, R., Oren, M., Mdm2 expression is induced by wild type p53 activity (1993) EMBO J., 12, pp. 461-468 
504 |a Saucedo, L.J., Carstens, B.P., Seavey, S.E., Albee, L.D., II, Perry, M.E., Regulation of transcriptional activation of mdm2 gene by p53 in response to UV radiation (1998) Cell Growth Differ., 9, pp. 119-130 
504 |a Eischen, C.M., Lozano, G., The Mdm network and its regulation of p53 activities: A rheostat of cancer risk (2014) Hum. Mutat., 35, pp. 728-737 
504 |a Li, M., Brooks, C.L., Wu-Baer, F., Chen, D., Baer, R., Gu, W., Mono- versus polyubiquitination: Differential control of p53 fate by Mdm2 (2003) Science, 302, pp. 1972-1975 
520 3 |a Leptin, a 16-kDa polypeptide hormone, is produced by the adipocyte and can also be synthesized by placenta. We previously demonstrated that leptin promotes proliferation and survival in placenta, in part mediated by the p53 pathway. In this work, we investigated the mechanisms involved in leptin down-regulation of p53 level. The human first trimester cytotrophoblastic Swan-71 cell line and human placental explants at term were used. In order to study the late phase of apoptosis, triggered by serum deprivation, experiments of DNA fragmentation were carried out. Exogenous leptin added to human placental explants, showed a decrease on DNA ladder formation and MAPK pathway is involved in this leptin effect. We also found that under serum deprivation condition, leptin decreases p53 levels and the inhibitory leptin effect is lost when cells were pretreated with 50 μM PD98059 or 10 μM LY29004; or were transfected with dominant negative mutants of intermediates of these pathways, suggesting that MAPK and PI3K signaling pathways are necessaries for leptin action. Additionally, leptin diminished Ser-46 p53 phosphorylation and this effect in placental explants was mediated by the activation of MAPK and PI3K pathways. Finally, in order to assess leptin effect on p53 half-life experiments with cycloheximide were performed and MDM-2 expression was analyzed. Leptin diminished p53 half-life and up-regulated MDM-2 expression. In summary, we provided evidence suggesting that leptin anti-apoptotic effect is mediated by MAPK and PI3K pathways. © 2015 Elsevier Ltd. All rights reserved.  |l eng 
536 |a Detalles de la financiación: Fondazione ART per la Ricerca sui Trapianti, ART 
536 |a Detalles de la financiación: Universidad de Buenos Aires 
536 |a Detalles de la financiación: Secretaría de Ciencia y Técnica, Universidad de Buenos Aires 
536 |a Detalles de la financiación: Agencia Nacional de Promoción Científica y Tecnológica, PS09/00119, PICT 2012-1366 
536 |a Detalles de la financiación: Instituto de Salud Carlos III, CM07/00025 
536 |a Detalles de la financiación: Consejo Nacional de Investigaciones Científicas y Técnicas 
536 |a Detalles de la financiación: ART is supported by a CONICET fellowship . APP is a research fellow supported by the Instituto de Salud Carlos III ( CM07/00025 ). This project was supported by the Universidad de Buenos Aires (UBACYT), the ANPCyT ( PICT 2012-1366 ) and the Instituto de Salud Carlos III ( PS09/00119 ), Spain. 
593 |a Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina 
593 |a Departamento de Bioquímica Médica y Biología Molecular, Hospital Universitario Virgen Macarena, Universidad de Sevilla, Sevilla, Spain 
690 1 0 |a ANTI-APOPTOTIC EFFECT 
690 1 0 |a LEPTIN 
690 1 0 |a MAPK AND PI3K SIGNAL TRANSDUCTION PATHWAYS 
690 1 0 |a MDM-2 
690 1 0 |a P53 
690 1 0 |a 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE 
690 1 0 |a LEPTIN 
690 1 0 |a LY 29004 
690 1 0 |a MITOGEN ACTIVATED PROTEIN KINASE 
690 1 0 |a PHOSPHATIDYLINOSITOL 3 KINASE 
690 1 0 |a PROTEIN INHIBITOR 
690 1 0 |a PROTEIN P53 
690 1 0 |a UNCLASSIFIED DRUG 
690 1 0 |a LEPTIN 
690 1 0 |a PHOSPHATIDYLINOSITOL 3 KINASE 
690 1 0 |a PROTEIN MDM2 
690 1 0 |a PROTEIN P53 
690 1 0 |a APOPTOSIS 
690 1 0 |a ARTICLE 
690 1 0 |a DNA FRAGMENTATION 
690 1 0 |a DOWN REGULATION 
690 1 0 |a ENZYME ACTIVITY 
690 1 0 |a EXPLANT 
690 1 0 |a FIRST TRIMESTER PREGNANCY 
690 1 0 |a HALF LIFE TIME 
690 1 0 |a HUMAN 
690 1 0 |a HUMAN CELL 
690 1 0 |a HUMAN TISSUE 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a PROTEIN PHOSPHORYLATION 
690 1 0 |a REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION 
690 1 0 |a SIGNAL TRANSDUCTION 
690 1 0 |a TRANSIENT TRANSFECTION 
690 1 0 |a TROPHOBLAST 
690 1 0 |a WESTERN BLOTTING 
690 1 0 |a CELL LINE 
690 1 0 |a CELL PROLIFERATION 
690 1 0 |a METABOLISM 
690 1 0 |a TROPHOBLAST 
690 1 0 |a APOPTOSIS 
690 1 0 |a CELL LINE 
690 1 0 |a CELL PROLIFERATION 
690 1 0 |a HUMANS 
690 1 0 |a LEPTIN 
690 1 0 |a MAP KINASE SIGNALING SYSTEM 
690 1 0 |a PHOSPHATIDYLINOSITOL 3-KINASES 
690 1 0 |a PROTO-ONCOGENE PROTEINS C-MDM2 
690 1 0 |a TROPHOBLASTS 
690 1 0 |a TUMOR SUPPRESSOR PROTEIN P53 
650 1 7 |2 spines  |a PLACENTA 
653 0 0 |a ly 29004; pd 98059 
700 1 |a Pérez-Pérez, A. 
700 1 |a Corrales Gutiérrez, I. 
700 1 |a Sánchez-Margalet, V. 
700 1 |a Varone, C.L. 
773 0 |d W.B. Saunders Ltd, 2015  |g v. 36  |h pp. 1266-1275  |k n. 11  |p Placenta  |x 01434004  |t Placenta 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-84947038203&doi=10.1016%2fj.placenta.2015.08.017&partnerID=40&md5=2e9fc6db9eac9f0a31a2a67c4eb512d0  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1016/j.placenta.2015.08.017  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_01434004_v36_n11_p1266_Toro  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01434004_v36_n11_p1266_Toro  |y Registro en la Biblioteca Digital 
961 |a paper_01434004_v36_n11_p1266_Toro  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 74119